Merck
CN
Search Within
文件类型

204-626-7

应用筛选条件
关键词:'204-626-7'
显示 1-14 共 14 条结果 关于 "204-626-7" 范围 技术文档
XP725 Antibody Number-Lot Number 071M4826
502 503 504 525 526 527 528 549 550 551 552 573 574 575 576 7.1 577 578 579 580 601 602 603 604 625 626 627 628 649 650 651 652 7.2 581 582 583 584 605 606 607 608 629
Product Information Sheet - 11719386001
697 498 001 Leupeptin 5 mg 25 mg 50 mg 100 mg 11 017 101 001 11 017 128 001 11 034 626 001 11 529 048 001 Pefabloc SC (AEBSF) 100 mg
Product Information Sheet - 11719394001
697 498 001 Leupeptin 5 mg 25 mg 50 mg 100 mg 11 017 101 001 11 017 128 001 11 034 626 001 11 529 048 001 Pefabloc SC (AEBSF) 100 mg
FlowCellect MitoPotential Red Kit, 100 Tests
Guirgi JV. Dead cell discrimination with 7-amino- actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry. 1992;13:204-208. 12 Related
XP725 Antibody List Lot 129K4830
2) A4721 9266 CYTH2 M NP_004219.3 y n/d y 202 Cytohesin-1 C8979 9267 CYTH1 M NP_004753.1 y n/d n/d 626 Rab9 R5404 9367 RAB9A M NP_001182257.1 y y y 647 ROCK-2 R8653 9475 ROCK2 P NP_004841.2 y y n/d 702
XP725 Antibody List Lot 129K4831
2) A4721 9266 CYTH2 M NP_004219.3 y n/d y 202 Cytohesin-1 C8979 9267 CYTH1 M NP_004753.1 y n/d n/d 626 Rab9 R5404 9367 RAB9A M NP_001182257.1 y y y 647 ROCK-2 R8653 9475 ROCK2 P NP_004841.2 y y n/d 702
XP725 Antibody List Lot 089K4791
2) A4721 9266 CYTH2 M NP_004219.3 y n/d y 202 Cytohesin-1 C8979 9267 CYTH1 M NP_004753.1 y n/d n/d 626 Rab9 R5404 9367 RAB9A M NP_001182257.1 y y y 647 ROCK-2 R8653 9475 ROCK2 P NP_004841.2 y y n/d 702
XP725 Worksheet for Lot Number 071M4826
C0992 625 4 2 1 1 GRP75 G4170 626 4 2 1 2 GRP75 G4170 627 4 2 1 3 GRP78 BiP G8918 628 4 2 1 4 GRP78 BiP G8918 629 4 2 1 5 GRP94 G4420 630 4 2 1 6 GRP94 G4420 631 4
List of Antibodies
d 622 Negative Control NA 623 Rab5 R7904 M y y y 624 Anti Cy3+Cy5 C0992 M NA NA NA 625 Rab 7 R8779 M y y y 626 Rab9 R5404 M y y y 627 RAD1 R5029 P y n/d n/d 628 Rad17 (C-terminal) (C-terminal) R8029
XP725 Antibody List
004153.2,NP_073183.1,NP_080163.1 M y y y 624 Anti Cy3+Cy5 625 Rab 7 R8779 29448, 19349, 7879 Rab7,RAB7 NP_076440.1,NP_033031.2,NP_004628.4 M y y y 626 Rab9 R5404 84589, 9367, 56382 RAB9,Rab9 NP_445910.1,NP_004242.1
XP725 Antibody List 013M4793
073183.1,NP_080163.1 M y y y 624 Anti Cy3+Cy5 C0992 625 Rab 7 R8779 29448, 19349, 7879 Rab7,RAB7 NP_076440.1,NP_033031.2,NP_004628.4 M y y y 626 Rab9 R5404 84589, 9367, 56382 RAB9,Rab9 NP_445910.1,NP_004242.1
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
25 µg 16-245 Conjugate Kinase EGFR, active 10 µg 14-531 EGFR (L858R), active 10 µg 14-626 EGFR (L861Q), active 10 µg 14-627 EGFR (T790M), active 10 µg 14-725 EGFR (T790M, L858R), active
Halal Certificate
) W364118 A17436 HC-23SI8763 625. ETHYL TRANS-3-HEXENOATE 98%, FG W334200 A26302 HC-23SIYV17 626. ETHYL VALERATE 98%, FG W246204 A58632 HC-23SIVH30 627. ETHYL VANILLIN 98%, FCC, FG W246409 A62715
Halal Certificate
) W364118 A17436 HC-22SIKR84 625. ETHYL TRANS-3-HEXENOATE 98%, FG W334200 A26302 HC-22SI5438 626. ETHYL VALERATE 98%, FG W246204 A58632 HC-22SIXY51 627. ETHYL VANILLIN 98%, FCC, FG W246409 A62715